Henry la Soya

Henry La Soya is a Senior Associate in Principal Investments at Novo Holdings, where responsibilities include engagement with portfolio companies and transaction due diligence for significant acquisitions and investments in the biopharma and pharmaceutical sectors. Prior experience includes consultancy roles at Roland Berger, focusing on financial modeling and strategic assessments in various industries, as well as contributions to projects related to growth strategies and market analysis. Earlier internships at Clarion and THRIVE Consulting provided exposure to product launch strategies and patient engagement in the biopharma sector. Henry La Soya holds a Bachelor of Science in Biological Engineering with a minor in Finance from the Massachusetts Institute of Technology.